1. Academic Validation
  2. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

  • Nature. 2002 Feb 14;415(6873):813-7. doi: 10.1038/415813a.
H Eric Xu 1 Thomas B Stanley Valerie G Montana Millard H Lambert Barry G Shearer Jeffery E Cobb David D McKee Cristin M Galardi Kelli D Plunket Robert T Nolte Derek J Parks John T Moore Steven A Kliewer Timothy M Willson Julie B Stimmel
Affiliations

Affiliation

  • 1 Nuclear Receptor Discovery Research, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. ex11957@gsk.com
Abstract

Repression of gene transcription by nuclear receptors is mediated by interactions with co-repressor proteins such as SMRT and N-CoR, which in turn recruit histone deacetylases to the chromatin. Aberrant interactions between nuclear receptors and co-repressors contribute towards acute promyelocytic leukaemia and thyroid hormone resistance syndrome. The binding of co-repressors to nuclear receptors occurs in the unliganded state, and can be stabilized by antagonists. Here we report the crystal structure of a ternary complex containing the peroxisome proliferator-activated receptor-alpha ligand-binding domain bound to the antagonist GW6471 and a SMRT co-repressor motif. In this structure, the co-repressor motif adopts a three-turn alpha-helix that prevents the carboxy-terminal activation helix (AF-2) of the receptor from assuming the active conformation. Binding of the co-repressor motif is further reinforced by the antagonist, which blocks the AF-2 helix from adopting the active position. Biochemical analyses and structure-based mutagenesis indicate that this mode of co-repressor binding is highly conserved across nuclear receptors.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-15372
    99.64%, PPAR拮抗剂